SCHEMBL457950

SCHEMBL457950

CCc1[c]ccc(F)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL206082 0.83
SCHEMBL1868132 0.79 TYR (0.35)
SCHEMBL10509760 0.79
SCHEMBL7220933 0.78 TAAR1 (0.36)
SCHEMBL1866526 0.78 GHSR (0.37)
SCHEMBL27795007 0.77
SCHEMBL2073678 0.77
SCHEMBL4074532 0.77
SCHEMBL7220390 0.77 SLC6A4 (0.36)
SCHEMBL6977336 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 119 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117836296-A Pyrazolopyridone compounds 百济神州有限公司 2024-04-05 CN claimed
CN-101851211-B Piperazine amide compound JIANGSU CHIA TAI TIANQING PHAR 2013-08-14 CN claimed
EP-2513064-A2 COMPOUNDS, COMPOSITIONS AND METHODS FOR CONTROLLING BIOFILMS Katholieke Universiteit Leuven, K.U. Leuven R&D (BE) 2012-10-24 EP claimed
CN-102558074-A Piperazine amide compound containing pyridazine substituent group GUANGZHOU INST BIOMED & HEALTH 2012-07-11 CN claimed
CN-102512421-A Novel application of piperazine acidamide compound in pharmacy GUANGZHOU INST BIOMED & HEALTH 2012-06-27 CN claimed
WO-2011080132-A2 COMPOUNDS, COMPOSITIONS AND METHODS FOR CONTROLLING BIOFILMS KATHOLIEKE UNIVERSITEIT LEUVEN, K.U. LEUVEN R&D (BE) 2011-07-07 WO claimed
CN-101851211-A Novel piperazine amide compound JIANGSU CHIA TAI TIANQING PHAR 2010-10-06 CN claimed
EP-2049490-A1 N-(BENZOYL)-O- [2- (PYRIDIN- 2 -YLAMINO) ETHYL]-L-TYROSINE DERIVATIVES AND RELATED COMPOUNDS AS A5B1 ANTAGONISTS FOR THE TREATMENT OF SOLID TUMORS Astra Zeneca AB (SE) 2009-04-22 EP claimed
US-20080045521-A1 PHENYLALANINE DERIVATIVES ASTRAZENECA AB (SE) 2008-02-21 US claimed
WO-2007141473-A1 N-(BENZOYL)-O- [2- (PYRIDIN- 2 -YLAMINO) ETHYL] -L-TYROSINE DERIVATIVES AND RELATED COMPOUNDS AS A5B1 ANTAGONISTS FOR THE TREATMENT OF SOLID TUMORS ASTRAZENECA AB (SE) 2007-12-13 WO claimed
CN-112654621-B Substituted naphthyridinone compounds useful as T cell activators 百时美施贵宝公司 2024-05-14 CN disclosed
CN-117836296-A Pyrazolopyridone compounds 百济神州有限公司 2024-04-05 CN disclosed
US-20230303608-A1 DITHIOLENE METAL COMPLEXES BASF SCHWEIZ AG (CH) 2023-09-28 US disclosed
EP-4182395-A1 DITHIOLENE METAL COMPLEXES BASF SE (DE) 2023-05-24 EP disclosed
WO-2022013081-A1 DITHIOLENE METAL COMPLEXES BASF SE (DE) 2022-01-20 WO disclosed
US-5356935-A Reductase inhibitors ELI LILLY AND COMPANY (US) 1994-10-18 US disclosed
US-5156669-A Fungicides and plant growth regulators BASF AKTIENGESELLSCHAFT (DE) 1992-10-20 US disclosed
EP-0144853-B1 SEMICARBAZIDE DERIVATIVES, PROCESSES FOR PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1990-09-26 EP disclosed
US-4725608-A ANTIINFLAMMATORY, ANALGESICS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1988-02-16 US disclosed
EP-0144853-A2 Semicarbazide derivatives, processes for preparation thereof and pharmaceutical composition comprising the same FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1985-06-19 EP disclosed